Search for: "AstraZeneca, AB"
Results 21 - 40
of 92
Sort by Relevance
|
Sort by Date
18 Mar 2016, 2:04 pm
Del. 2015), and AstraZeneca AB v. [read post]
2 Feb 2016, 12:46 pm
”); Astrazeneca AB v. [read post]
21 Nov 2015, 5:54 am
Robinson in AstraZeneca AB, et al. v. [read post]
13 Nov 2015, 2:42 pm
Robinson in AstraZeneca AB, et al. v. [read post]
6 Sep 2015, 12:30 am
Last week I predicted that the High Court would affirm the finding of five judges of the Federal Court of Australia that AstraZenenca’s patents covering low-dosage forms of the cholesterol-lowering drug marketed as CRESTOR (having the active ingredient rosuvastatin) are invalid on grounds of obviousness.In the much-anticipated decision in AstraZeneca AB v Apotex Pty Ltd (et al) [2015] HCA 30, five judges of the High Court, in four distinct concurring opinions, have… [read post]
29 Aug 2015, 9:08 pm
At 10.15am this coming Wednesday (2 September 2015) the Australian High Court will hand down its decision in the appeal by AstraZeneca AB against last year’s ruling, by a a special five-judge panel of the Federal Court of Australia, that its two patents relating to the cholesterol-lowering drug marketed as CRESTOR (having the active ingredient rosuvastatin) are invalid.The decision will be significant in clarifying the law relating to obviousness in Australia. [read post]
22 Jun 2015, 9:24 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 50 [week ending on Sunday 7 June] - Swiss claims | Italian-sounding trade marks for cosmetics | “IP litigation and Enforcement” event | Saving WiFi | Spy scandal at the EPO | Rihanna v DC Comics | KitKat trade mark | Taste trade marks in the Netherlands | Connectivity and human rights | Trade secrets, client confidentiality and privilege | 3-d printing and counterfeiting | Ericsson v Apple in the… [read post]
15 Jun 2015, 7:13 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 49 [week ending on Sunday 31 May] - Another copyright-exhaustion-and-software reference to the CJEU | ORO trade marks and GC | Patent Reform in EU | Copyright in the Bahamas | More and more references to the CJEU: communication to the public and linking | Trade secrets and the FoMo phenomenon | Independence of EPO’s BoA.Never too late 48 [week ending on Sunday 31 May] - The… [read post]
8 Jun 2015, 4:20 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 48 [week ending on Sunday 31 May] - The meaning of EPO appeal system | 3D Printing and the law | Epo and external investigation firms | Umbrella designs | US Supreme Court in Commil USA, LLC v Cisco Systems | European Inventor Award | FIFA and brand integrity | Warner-Lambert v Actavis | Wine in Black GmbH v OHIM | IP and busking | Swiss-style claims.Never too late… [read post]
1 Jun 2015, 3:33 pm
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 47 [week ending on Sunday 24 May] - Nicolas Sarkozy and the IP | Another reference on TM licences to the CJEU | UPC test-drive | Swatch v Swatchball | New Lisbon Treaty on appellations of origin and geographical indications | UP reneal fees | Synthon v Teva | GC on Yoshida | UPC Court fees event | EPO staff under fire | The trade-secret option | Damages |AstraZeneca AB & Another v… [read post]
25 May 2015, 4:15 am
, Paul Inman and Ailsa Carter, have summarised last week's decision from the Court of Appeal in AstraZeneca AB & Another v KRKA dd Novo Mesto & Another [2015] EWCA Civ 484.* F1 ends up in hot water - no similarity to F1H2OIn Case T-55/13 the General Court of the European Union deals with Formula One Licensing BV's opposition against Idea Marketing SA’s Community trade mark application for 'F1H2O'. [read post]
22 May 2015, 10:38 am
., Paul Inman and Ailsa Carter, who have summarised a decision from the Court of Appeal yesterday, AstraZeneca AB & Anor v KRKA dd Novo Mesto & Anor [2015] EWCA Civ 484. [read post]
18 May 2015, 5:55 am
.' Astrazeneca AB v. [read post]
17 May 2015, 6:28 am
3M, however, lives on in the continuing failure of all attempts at legislative correction to produce laws consistent with the approach taken in the rest of the developed world.In the latest chapter of this ongoing saga, on the 13th and 14th of May the Australian High Court heard oral arguments in the appeal by pharmaceutical company AstraZeneca AB against last year’s ruling of an expanded five-judge Full Bench of the Federal Court of Australia that its two patents… [read post]
16 Apr 2015, 9:59 pm
As set forth in the opinion, AstraZeneca's lawsuit against Apotex was part of the "second wave" of ANDA litigation, wherein the District Court apportioned into two sets of four defendants from the eight ANDA filers sued by AstraZeneca in the Southern District of New York starting at the end of the last century. [read post]
7 Apr 2015, 11:49 am
We previously affirmedthe district court’s decision in an earlier phase of the samelitigation holding that Apotex had infringed certainpatents held by AstraZeneca AB and related parties(collectively, “Astra”). [read post]
9 Mar 2015, 1:46 pm
And from the FDA announcement about this Endocrinologic and Metabolic Drugs Advisory Committee Meeting, as regards the Agenda: During the morning session, the committee will discuss the results of the cardiovascular outcomes trial (CVOT), Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus, for new drug application (NDA) 22350, Onglyza (saxagliptin) and NDA 200678, Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets manufactured/marketed… [read post]
5 Mar 2015, 5:52 am
AstraZeneca AB v. [read post]
12 Feb 2015, 3:15 pm
Roach v. [read post]
19 Dec 2014, 6:40 am
" AstraZeneca AB v. [read post]
